- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| DATAMEDS AI Aktie jetzt für 0€ handeln | |||||
| 27.08. | DataMEDS AI, Inc.: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid | 542 | ACCESS Newswire | 50% off available online at www.TolloHealth.Shop and www.CorexaRx.comSoon to become available at Health Lives Here pharmacies and on Amazon.com TAMPA, FL / ACCESS Newswire / August 27, 2026 / DataMeds... ► Artikel lesen | |
| 19.08. | DataMEDS AI reports Q2 results | 1 | Seeking Alpha | ||
| 18.08. | DataMeds AI, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 17.08. | DataMEDS AI, Inc.: DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update | 420 | ACCESS Newswire | Revenues grew 14% reaching $1.779M in Q2/26, beating management projectionsCorporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from... ► Artikel lesen | |
| 17.08. | DataMeds AI, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | DataMEDS AI, Inc.: DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities | 695 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure... ► Artikel lesen | |
| 12.08. | DataMeds AI subsidiary adds GLP-1 drugs, reports July revenue | 5 | Investing.com | ||
| 12.08. | DataMEDS AI, Inc.: DataMeds AI Provides Update on Corexa Health's Pharmacy Division | 1.473 | ACCESS Newswire | GLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet & Galectovid, and dietary supplement Tollovid now availableRevenue... ► Artikel lesen | |
| 10.08. | DataMeds AI renames pharmacy subsidiaries to Corexa | 1 | Investing.com | ||
| 10.08. | DataMEDS AI, Inc.: DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division | 1.239 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| 07.08. | DataMeds AI, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 06.08. | DataMEDS AI, Inc.: DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date | 456 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| 05.08. | DataMEDS AI, Inc.: DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here" | 502 | ACCESS Newswire | Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient... ► Artikel lesen | |
| 04.08. | DataMeds AI, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07. | DataMEDS AI, Inc.: DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid and Galactovid | 711 | ACCESS Newswire | Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company")... ► Artikel lesen | |
| 29.07. | DataMEDS AI, Inc.: DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License | 600 | ACCESS Newswire | Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX PlatformHealthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT... ► Artikel lesen | |
| 27.07. | DataMEDS updates meme coin distribution record date to August 7 | 2 | Investing.com | ||
| 27.07. | DataMEDS AI verschiebt Stichtag für Meme-Coin-Ausschüttung und erhöht Zuteilungsverhältnis | 3 | Investing.com Deutsch | ||
| 27.07. | DataMEDS AI, Inc.: DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 422 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 22.07. | DataMEDS AI, Inc.: DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets | 459 | ACCESS Newswire | Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS... ► Artikel lesen |
1 2 3 4 5 Weiter >>
100 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANOPY GROWTH | 0,830 | -1,19 % | Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? | ||
| EYEPOINT | 3,960 | +0,51 % | EyePoint drops as TD Cowen becomes latest to downgrade on late-stage trial setback | ||
| FILANA THERAPEUTICS | 0,695 | -1,56 % | Filana Therapeutics, Inc.: Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update | AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for... ► Artikel lesen | |
| COMPASS PATHWAYS | 11,500 | 0,00 % | Compass Pathfinder Limited: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 9,650 | -1,98 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer | NORWOOD, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage company focused on developing promising new therapies... ► Artikel lesen | |
| DARE BIOSCIENCE | 0,719 | +0,83 % | Daré Bioscience, Inc.: Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth | New NIH award will provide approximately $908,000 in year-long support of preclinical development, with potential for an additional future-year grant of approximately $1.3 million DARE-PTB2 is an... ► Artikel lesen | |
| CITIUS PHARMACEUTICALS | 0,602 | +0,23 % | Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | $7.1 Million in revenue for the first nine months of fiscal 2026 from commercial sales of LYMPHIR ®
$17 million in cash and cash equivalents as of June 30, 2026
Expanded... ► Artikel lesen | |
| ELEDON PHARMACEUTICALS | 2,560 | 0,00 % | Eledon beantragt US-Zulassung für entscheidende Studie mit Tegoprubart bei Inselzelltransplantation | ||
| EXICURE | 0,810 | -5,81 % | Exicure, Inc.: Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics... ► Artikel lesen | |
| CHINA SXT PHARMACEUTICALS | 2,230 | +17,06 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.08.2026 | The following instruments on XETRA do have their first trading 10.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.08.2026
Aktien
1 KYG472811036 IMC Rare Earths Ltd.
2... ► Artikel lesen | |
| COSMOS HEALTH | 0,227 | +1,79 % | Cosmos Health Inc.: A Company Transformed - 2026 Year-to-Date | A Comprehensive Corporate Summary - January 1, 2026 through August 31, 2026 Revenue record set three consecutive quarters: FY2025 $65.3M (+20%) ? Q1 2026 $17.93M (+31%) ? Q2 2026 $18.99M (+28.8%) ?... ► Artikel lesen | |
| CHAMPIONS ONCOLOGY | 4,460 | +3,24 % | Champions Oncology, Inc.: Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging | New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single, U.S.-based workflow HACKENSACK... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 6,750 | 0,00 % | CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report | ||
| CDT EQUITY | 0,700 | -6,59 % | CDT Equity Inc.: CDT Provides Capital Update and Confirms No Nasdaq Deficiencies | NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today announced that, following the recent issuance of shares... ► Artikel lesen | |
| ANBIO BIOTECHNOLOGY | 5,550 | -1,77 % | Anbio Biotechnology - 6-K, Report of foreign issuer |
Das Unternehmen DATAMEDS AI INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (-0,01 %) liegt der Kurs bei 0,961 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DATAMEDS AI INC finden Sie auf Wallstreet Online.